Ask a doctor about a prescription for HIRUDOID 3 mg/g OINTMENT
PACKAGE LEAFLET: INFORMATION FOR THE USER
Hirudoid 3 mg/g ointment
Sodium chondroitin sulfate
Read all of this leaflet carefully before you start using this medicine because it contains important information for you.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist.
Contents of the package leaflet:
Hirudoid is a medicine that contains sodium chondroitin sulfate as the active ingredient, and has properties that favor blood flow.
This medicine is indicated for:
the local symptomatic relief of superficial venous disorders such as heaviness and tightness in legs with varices in adults
the local symptomatic relief of superficial hematomas caused by bruises in adults and children over 1 year of age.
You should consult a doctor if it worsens or does not improve after 5 days.
Do not use Hirudoid
Warnings and precautions
Consult your doctor or pharmacist before starting to use Hirudoid.
In case of venous problems caused by blood clots (such as thromboembolism, obstruction of a blood vessel that hinders blood flow), it is recommended to apply the product gently and without massage.
Using Hirudoid with other medicines
Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines.
It is not recommended to apply other topical preparations to the same area without consulting your doctor.
Pregnancy, breastfeeding, and fertility
If you are pregnant or breastfeeding, think you might be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.
You should not use Hirudoid during pregnancy or breastfeeding unless your doctor advises you to do so.
Driving and using machines
No effects on the ability to drive vehicles or use machinery have been described.
Hirudoidcontains propyl parahydroxybenzoate (E-216), methyl parahydroxybenzoate (E-
218), cetearyl alcohol, and lanolin
This medicine may cause allergic reactions (possibly delayed) because it contains propyl parahydroxybenzoate (E-216) and methyl parahydroxybenzoate (E-218), and local reactions on the skin (such as contact dermatitis) because it contains cetearyl alcohol and lanolin.
Follow exactly the administration instructions of the medicine contained in this leaflet or as indicated by your doctor or pharmacist. If in doubt, ask your doctor or pharmacist.
This medicine is for topical use (exclusively on the skin). The recommended dose is:
Superficial venous disorders
Adults:apply a thin layer of gel or ointment to the affected area 2 to 3 times a day, distributing it with a light massage to facilitate penetration.
Wash your hands after each application to avoid unintentional contact with eyes and mucous membranes.
The average duration of treatment is usually between 1 and 2 weeks. If symptoms worsen or persist after 5 days of treatment, you should consult a doctor.
Children under 18 years:do not use without medical supervision.
Hematomas:
Adults and children over 1 year:apply a thin layer of gel or ointment to the affected area 2 to 3 times a day, distributing it with a light massage to facilitate penetration.
Wash your hands after each application to avoid unintentional contact with eyes and mucous membranes. The average duration of treatment for hematomas is usually less than 10 days. If symptoms worsen or persist after 5 days of treatment, you should consult a doctor. Children under 1 year:do not use without medical supervision.
If you use more Hirudoid than you should
If you have used more Hirudoid than you should or in case of accidental ingestion, consult the Toxicology Information Service. Telephone 91 562 04 20, indicating the medicine and the amount ingested.
Accidental ingestion of large amounts of Hirudoid gel due to its content of isopropyl alcohol may cause symptoms of acute alcohol intoxication.
In case of possible alcohol intoxication, special therapeutic measures should be initiated immediately.
If you forget to use Hirudoid
Do not apply a double dose to make up for forgotten doses.
You should continue treatment as normal without taking any particular action.
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.
Like all medicines, Hirudoid can cause side effects, although not everybody gets them.
It has been observed that very rarely (affects less than 1 in 10,000 patients), allergic reactions may appear at the application site, which can manifest as itching and irritation, and which disappear when treatment is discontinued.
If you experience side effects, consult your doctor or pharmacist, even if they are not listed in this leaflet.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date stated on the packaging after EXP. The expiry date is the last day of the month indicated.
This medicine does not require special storage conditions.
You should discard the tube 12 months after first opening. Write the opening date in the space provided on the carton.
Medicines should not be disposed of via wastewater or household waste. Place the packaging and any unused medicines in the SIGRE collection point at your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.
Composition of Hirudoid
Appearance of the product and pack contents
Hirudoid is available in lacquered aluminum tubes with 40 grams of ointment.
Marketing authorisation holder
Laboratorio STADA S.L. Frederic Mompou, 5
08960 Sant Just Desvern (Spain) info@stada.es
Manufacturer
Mobilat Produktions GmbH
Luitpoldstrasse 1
85276 Pfaffenhofen
Germany
or
STADA Arzneimittel AG Stadastrasse 2-18
61118 - Bad Vilbel
Germany
or
Wagener & Co. GmbH
Lohesch 60
49525 Lengerich
Germany
Date of last revision of this leaflet:March 2012
“Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/”
Discuss dosage, side effects, interactions, contraindications, and prescription renewal for HIRUDOID 3 mg/g OINTMENT – subject to medical assessment and local rules.